The Global Hemodialysis and Peritoneal Dialysis Market size is expected to reach USD 119.15 billion in 2030 from USD 72.95 billion in 2021, registering a CAGR of 6.2% through the forecast period. The market growth is driven by a significant rise in the number of patients with ESRD (end-stage renal disease), an increased dialysis requirement, shortage of organ donors, the health-risk related to organ transplant, and expansion of the geriatric population base across the globe.
Kidney failures and disorders are one of the leading causes of death worldwide. According to a report published by the University of California, approximately two million people suffer from end-stage renal diseases and chronic kidney diseases globally. Hemodialysis and peritoneal dialysis are the two types of dialysis used to treat kidney failure or diseases. In 2015, over 120,000 patients in the U.S. initiated dialysis for the treatment of end-stage renal disease. Out of these patients, and 0.4% use home hemodialysis as their initial modality, around 10% receive peritoneal dialysis, and nearly 90% receive hemodialysis at a dialysis center. However, rates of mortality and quality of life are similar among patients treated with peritoneal or hemodialysis dialysis.
Request a Sample@ https://www.qyresearchmedical.com/sample/119163
With inappropriate functioning of kidneys, waste products such as urea and creatinine in the blood start to accumulate. Dialysis is a technique used to remove these waste products in people suffering from chronic renal failure. Broadly speaking, there are two types of dialysis, namely, hemodialysis and peritoneal dialysis. In the former type, blood is pumped out of blood vessels, purified by a dialyzer, and then returned to the body via vascular access. In the later, the procedure remains almost the same, but the inner lining of the stomach, which is also called the peritoneum, is used as a filter for the purification of the blood.
Rising prevalence of kidney diseases due to alcoholism among masses will boost the global hemodialysis & peritoneal dialysis market share. Moreover, increased preference of patients toward home hemodialysis due to its patient-centered approach, effective results, and cost-effectiveness may supplement revenue share over the analysis period.
Positive initiatives undertaken by regional governments are positively impacting hemodialysis and peritoneal dialysis industry growth. For instance, the government in Trinidad has launched a new dialysis facility in South Trinidad on 3rd August 2020. The facility will be assisting 130,000 clients in the nearby areas in getting hemodialysis care and has the capacity to provide hemodialysis care for nearly 66 clients per week. The unit has an independent water treatment system and a private high dependency room to minimize interruption of service.
The key factors that may restrict industry growth are risks and complications associated with peritoneal dialysis and hemodialysis, high cost of dialysis treatment, high chances of infections, low patient survival rate, and poor reimbursement scenario in developing countries.
Regional Outlook:
In terms of the regional landscape, North America is estimated to contribute significantly towards the hemodialysis and peritoneal dialysis market revenue share, showcasing a notable CAGR of 5.9% through 2030. The robust growth rate can be attributed to the availability of medical reimbursements facility, rapid technological advancements, along with the presence of hi-tech healthcare infrastructure across the region.
In 2019, Asia Pacific accounted for about 42.3% of the market share and is expected to register the highest growth rate of 7.5% through the coming years on account of the growing prevalence of kidney disorders, rise in old age population, and improvement in the healthcare infrastructure across the region.
Type Outlook:
The hemodialysis type segment is dominating the global hemodialysis and peritoneal dialysis market by holding an 80% share and is estimated to showcase a CAGR of 6.4% over the analysis period.
The peritoneal dialysis segment will gain traction as the treatment is gaining popularity with its effective results. Peritoneal dialysis is associated with a 16% lower risk of hemorrhagic stroke as compared to hemodialysis. It can improve patient survival, lower infection risk in patients with end-stage renal disease, preserve residual renal function while reducing financial stress to the government as it is majorly a home-based treatment.
End-use Outlook:
In 2019, the in-center dialysis segment held around 68.5% of the industry share and is estimated to garner significant revenue through 2030 due to a significant rise in the number of dialysis clinics worldwide.
The service segment garnered USD 49.80 billion in terms of revenue before 2019 and is set to gain traction due to growth in home-based dialysis services offered by key industry players.
Market-O-Nomics:
- The Global Hemodialysis and Peritoneal Dialysis Market size is expected to reach USD 119.15 billion in 2030 from USD 72.95 billion in 2019, registering a CAGR of 6.2% through the forecast period.
- The market growth is driven by a significant rise in the number of patients with ESRD (end-stage renal disease), an increased dialysis requirement, shortage of organ donors, the health-risk related to organ transplant, and expansion of the geriatric population base across the globe.
- In 2015, over 120,000 patients in the U.S. initiated dialysis for the treatment of end-stage renal disease. Out of these patients, and 0.4% use home hemodialysis as their initial modality, around 10% receive peritoneal dialysis, and nearly 90% receive hemodialysis at a dialysis center. However, rates of mortality and quality of life are similar among patients treated with peritoneal or hemodialysis dialysis.
- Rising prevalence of kidney diseases due to alcoholism among masses will boost the global hemodialysis & peritoneal dialysis market share.
- In terms of the regional landscape, North America is estimated to contribute significantly towards the hemodialysis and peritoneal dialysis market revenue share, showcasing a notable CAGR of 5.9% through 2030.
- In 2018, Asia Pacific accounted for about 42.3% of the market share and is expected to register the highest growth rate of 7.5% through 2030.
- The hemodialysis type segment is dominating the global hemodialysis and peritoneal dialysis market by holding 80% share and is estimated to showcase a CAGR of 6.4% over the analysis period.
- In 2018, the in-center dialysis segment held 68.5% of the industry share and is estimated to garner significant revenue through 2030 due to a significant rise in the number of dialysis clinics worldwide.
- The service segment garnered USD 49.80 billion in terms of revenue in 2018 and is set to gain traction due to growth in home-based dialysis services offered by key industry players.
- Outset, a pioneering medical technology company specializing in dialysis machines, gained FDA clearance its Tablo Hemodialysis System, an at-home use dialysis machine, in April 2020.
- The key factors that may restrict industry growth are risks and complications associated with peritoneal dialysis and hemodialysis, high cost of dialysis treatment, high chances of infections, low patient survival rate, and poor reimbursement scenario in developing countries.
Competitive Landscape:
The leading companies in the sector include Fresenius Medical Care AG & Co., DaVita Healthcare Partners, Baxter International, B. Braun Melsungen AG, Nikkiso, Nipro Corporation, Diaverum Deutschland GmbH, Medicators, Asahi Kasei Corporation, and NxStage Medical.
Outset, a pioneering medical technology company specializing in dialysis machines, gained FDA clearance its Tablo Hemodialysis System, an at-home use dialysis machine, in April 2020.
In 2022, in collaboration with The Johns Hopkins Hospital, Fresenius Medical Care AG & Co. KGaA announced plans to open 8 new dialysis centers. These centers would be located in Baltimore, U.S., to meet the growing demand within the region.
Baxter, an American multinational health care company, received CE mark approval to bring HOMECHOICE CLARIA in the European market in 2015. This device is ideal for peritoneal dialysis in home-based settings.
Segments Covered in the report
This report forecasts revenue growth at a global, regional & country level, and provides an analysis of the market trends in each of the sub-segments from 2022 to 2030. For the purpose of this study,have segmented the Hemodialysis and Peritoneal Dialysis market on the basis of products & services, modality, water treatment systems, end-use, and region:
Products & Services Type (Revenue, USD Million; 2022–2030)
- Hemodialysis
-
- Machines
-
-
- Center Use hemodialysis machines
- Home Use hemodialysis machines
-
- Consumables
- Dialyzers
- On the basic of material
- Dialyzers
-
-
-
- Synthetic
- Cellulose
- On the basic of flux
- High flux
- Low Flux
-
-
- Hemodialysis analyzer product
- AV fistula
- Arteriovenous grafts
- Tunneled hemodialysis catheter
- Temporary hemodialysis catheter
- Bloodline
- Hemodialysis Concentrates
- Alkaline
- Acidic
- Others
- Services
- In House
- Clinic
- Peritoneal Dialysis
- Concentrates
- Machines
- Catheters
- Short term
- Long term
- Transfer sets
- Services
Modality (Revenue, USD Million; 2022–2030)
- Hemodialysis
-
- Conventional long-term
- Short
- nocturnal
- Peritoneal Dialysis
- Continuous ambulatory peritoneal dialysis
- Automated peritoneal dialysis
Water Treatment System (Revenue, USD Million; 2022–2030)
- Hemodialysis water treatment system
-
- Central water disinfection systems
-
-
- Chemical disinfection systems
- Heat disinfection systems
- Accessories
- Portable water disinfection systems
-
- Peritoneal water treatment system
End-Use (Revenue, USD Million; 2022–2030)
- In-Center Dialysis
- Hospitals
- Independent Dialysis Centers
- Home Dialysis
-
- Peritoneal Dialysis
- Home Hemodialysis
Regional Outlook (Revenue in USD Million; 2022–2030)
- North America
-
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Brazil
- Middle East & Africa
Buy quantitative research Report at discounted price – USD 1500 https://www.qyresearchmedical.com/report/checkout/119163/1500
You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333
Blog: https://www.novaoneadvisor.com/
Blog: https://www.visionresearchreports.com/
About Us
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us:
URL – http://www.qyresearchmedical.com/
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/